Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine

Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine

US Patent 10603331 · Granted Mar 31, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds for the treatment of epilepsy2025
Heterocyclic compounds for the treatment of epilepsy2025
Methods of treating anxiety by administering a substituted quinolone2022
Methods of treating anxiety by administering a substituted quinolone2022
Methods of treating anxiety by administering a substituted quinolone2022
Methods of treating anxiety by administering a substituted quinolone2022
Pyrimidine compound2020
Pyrimidine compound2020
Piperazine-substituted benzothiophenes for treatment of mental disorders2020
Cyanotriazole compounds2020
Dihydrate of benzothiophene compound or of a salt thereof, and process for produ2019
Method for treating depression and/or depression status with substituted quinoxa2018